Anzalone, M., Karam, S. A., Briting, S. R. R., Petersen, S., Thomsen, M. B., Babcock, A. A., Landau, A. M., Finsen, B. & Metaxas, A. (2025). Serotonin-2B receptor (5-HT_2BR) expression and binding in the brain of APP_swe/PS1_dE9 transgenic mice and in Alzheimer's disease brain tissue. Neuroscience Letters, 844, Article 138013. https://doi.org/10.1016/j.neulet.2024.138013

Arjmand, S., Lindström, M. B., Sellgren, C. M. & Wegener, G. (2025). Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics. European psychiatry : the journal of the Association of European Psychiatrists, 1-5. Advance online publication. https://doi.org/10.1192/j.eurpsy.2025.14

Binda, K. H., Real, C. C., Simonsen, M. T., Grove, E. K., Bender, D., Gjedde, A., Brooks, D. J. & Landau, A. M. (2025). Acute transcutaneous auricular vagus nerve stimulation modulates presynaptic SV2A density in healthy rat brain: An in vivo microPET study. Psychophysiology, 62(1), Article e14709. https://doi.org/10.1111/psyp.14709

Diniz, C. R. A. F., Crestani, A. P., C Casarotto, P., Biojone, C., Cannarozzo, C., Winkel, F., Prozorov, M. A., Kot, E. F., Goncharuk, S. A., Benette Marques, D., Zacharias, L. R., Autio, H., Pryiadrashini Sahu, M., Borges-Assis, A. B., Pereira Leite, J., Mineev, K. S., Castren, E. & Resstel, L. B. M. (2025). Fluoxetine and Ketamine Enhance Extinction Memory and Brain Plasticity by Triggering the p75 Neurotrophin Receptor Proteolytic Pathway. Biological Psychiatry, 97(3), 248-260. https://doi.org/10.1016/j.biopsych.2024.06.021

Godoy, L. D. & Wegener, G. (2025). Acta Neuropsychiatrica embraces full open access: towards a new era of global knowledge sharing. Acta Neuropsychiatrica, 37, e2. Article e2. https://doi.org/10.1017/neu.2024.66

Jensen, N. J., Porse, A. J., Wodschow, H. Z., Speyer, H., Krogh, J., Marner, L., Gejl, M., Gjedde, A. & Rungby, J. (2025). Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis. Journal of Clinical Endocrinology and Metabolism, 110(2), e525-e537. https://doi.org/10.1210/clinem/dgae570

Kai, L. M., Parada Iglesias, L., Kõiv, K., Harro, J. & Wegener, G. (2025). Ultrasonic vocalisations in the Flinders Sensitive Line rat, a genetic animal model of depression. Acta Neuropsychiatrica, 37, Article e3. https://doi.org/10.1017/neu.2024.61

Krogsbaek, M., Larsen, N. Y., Yarmahmoudi, F., Søndergaard, J., Landau, A. M., Sanchez, C. & Nyengaard, J. R. (2025). Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus. Psychoneuroendocrinology, 171, Article 107225. https://doi.org/10.1016/j.psyneuen.2024.107225

Østergaard, H. D., Pallesen, K. J., Nielsen, M. N., Fjorback, L., Juul, L. & Winterdahl, M. (2025). Effects of mindfulness-based stress reduction on neuropeptide Y plasma levels in stressed individuals. Journal of Psychiatric Research, 181, 400-404. https://doi.org/10.1016/j.jpsychires.2024.12.011

Saboori Amleshi, R., Ilaghi, M., Rezaei, M., Zangiabadian, M., Rezazadeh, H., Wegener, G. & Arjmand, S. (2025). Predictive utility of artificial intelligence on schizophrenia treatment outcomes: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 169, 105968. Article 105968. https://doi.org/10.1016/j.neubiorev.2024.105968

Silva, N. R., Arjmand, S., Domingos, L. B., Chaves-Filho, A. M., Mottin, M., Real, C. C., Waszkiewicz, A. L., Gobira, P. H., Ferraro, A. N., Landau, A. M., Andrade, C. H., Müller, H. K., Wegener, G. & Joca, S. R. L. (2025). Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression. Pharmacological Research, 211, 107545. Article 107545. https://doi.org/10.1016/j.phrs.2024.107545